Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

US Patent 8535678 · Granted Sep 17, 2013

Estimated economic value: $38,999,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Periostin antibodies and methods of using the same2025
Universal immune receptor expressed by T cells for the targeting of diverse and 2024
Anti-TEM1 antibodies and uses thereof2021
Universal immune receptor expressed by T cells for the targeting of diverse and 2021
Isolated B7-H4 specific compositions and methods of use thereof2021
Universal immune receptor expressed by T cells for the targeting of diverse and 2019
Isolated B7-H4 specific compositions and methods of use thereof2019
Bispecific binding proteins that bind CD40 and mesothelin2019
Anti-TEM1 antibodies and uses thereof2018
Universal immune receptor expressed by T cells for the targeting of diverse and 2017
Anti-TEM1 antibodies and uses thereof2017
Isolated B7-H4 specific compositions and methods of use thereof2016